Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05187507
Other study ID # UDDS-Pedo-06-2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 25, 2021
Est. completion date December 1, 2021

Study information

Verified date December 2021
Source Damascus University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Since plaque control forms the basis for caries prevention, the type of toothpaste and its constituents becomes more important. Toothpaste containing fluoride are widely popular and fluorides have been historically reported to have effects against dental caries. However, the fluoride safe doses are still discussed ,because fluoride has toxicity and causing fluorosis. The aim of the current research is to find alternative agent that can be used without side effects.


Description:

Participants will be examined to ensure that they have met the smple entrey criteria,then the participants will be randomly assigned to four groups each one according to a group: 1. A group of children using low-fluoridated toothpaste (500ppm) 2. A group of children using fluoridated toothpaste (1450ppm) 3. A group of children using theobromine toothpaste (2%) 4. A group of children using low-fluoridated toothpaste (4%) The researcher will teach the participants how to brush using (tell-show-do)technique. - The brushing method that will be used is the fones technique. - Brushing duration must be 2minutes. - Frequency of brushing must be twice a day - The amount of toothpaste used is pea size. Mechanism of examination and follow up: A thorough scaling and plaque removal was conducted and the children were advised to brush their teeth using their regular toothpaste for a week before starting the research. Gingival will be evaluated with gingival index (loe and silness)


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date December 1, 2021
Est. primary completion date November 1, 2021
Accepts healthy volunteers No
Gender All
Age group 6 Years to 9 Years
Eligibility Inclusion Criteria: - Children of age group 6to 9 years. - Participant must have least 20 teeth free from dental cries on both buccal and lingual surfaces of the teeth. - Cooperative children having behavioral rating (positive or definitively positive)according to frankel's behavior rating scale. - Children who are not on any medication prior or during the study period Exclusion Criteria: - children with systemic diseases and medically compromising conditions. - children undergoing orthodontic treatment or with an intraoral prosthesis. - children who could not brush their teeth or rinse on their own. - Allergic to any of the toothpaste ingredient used the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Evaluation of the effectiveness of low- fluoridated toothpaste.
Children will be given low- fluoridated toothpaste, plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface. Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Evaluation of the effectiveness of fluoridated toothpaste.
Children will be given e fluoridated toothpaste, plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface. Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Evaluation of the effectiveness of theobromine toothpaste (2%) toothpaste.
Children will be given theobromine toothpaste(2%),plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface. Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).
Evaluation of the effectiveness of theobromine toothpaste(4%) toothpaste.
Children will be given theobromine toothpaste(4%),plaque score in groups will be assess pre given toothpaste in baseline,aweek,2week,and after 3weeks by using the TMQHPI for both buccal and lingual surface. Gingivalitis will be assess pre given toothpaste,aweek,2weeks,and after 3weeks by using gingival index (loe and silness).

Locations

Country Name City State
Syrian Arab Republic Damascus University Damascus

Sponsors (1)

Lead Sponsor Collaborator
Damascus University

Country where clinical trial is conducted

Syrian Arab Republic, 

References & Publications (5)

Farooq I, Samad Khan A, Moheet IA, Alshwaimi E. Preparation of a toothpaste containing theobromine and fluoridated bioactive glass and its effect on surface micro-hardness and roughness of enamel. Dent Mater J. 2021 Mar 31;40(2):393-398. doi: 10.4012/dmj.2020-078. Epub 2020 Nov 19. — View Citation

Lakshmi A, Vishnurekha C, Baghkomeh PN. Effect of theobromine in antimicrobial activity: An in vitro study. Dent Res J (Isfahan). 2019 Mar-Apr;16(2):76-80. — View Citation

Lippert F. The effects of fluoride, strontium, theobromine and their combinations on caries lesion rehardening and fluoridation. Arch Oral Biol. 2017 Aug;80:217-221. doi: 10.1016/j.archoralbio.2017.04.022. Epub 2017 Apr 20. — View Citation

Premnath P, John J, Manchery N, Subbiah GK, Nagappan N, Subramani P. Effectiveness of Theobromine on Enamel Remineralization: A Comparative In-vitro Study. Cureus. 2019 Sep 17;11(9):e5686. doi: 10.7759/cureus.5686. — View Citation

Thorn AK, Lin WS, Levon JA, Morton D, Eckert GJ, Lippert F. The effect of theobromine on the in vitro de- and remineralization of enamel carious lesions. J Dent. 2020;103S:100013. doi: 10.1016/j.jjodo.2020.100013. Epub 2020 Feb 17. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical evaluation of using low- fluoridaed toothpaste for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
1 week
Primary Clinical evaluation of using low- fluoridaed toothpaste for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
2 week
Primary Clinical evaluation of using low- fluoridaed toothpaste for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
3 week
Primary Clinical evaluation of using fluoridated toothpaste for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
1 week
Primary Clinical evaluation of using fluoridated toothpaste for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
2 week
Primary Clinical evaluation of using fluoridated toothpaste for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
3 week
Primary Clinical evaluation of using theobromine toothpaste(2%) for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
1 week
Primary Clinical evaluation of using theobromine toothpaste(2%) for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
2 week
Primary Clinical evaluation of using theobromine toothpaste(2%) for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
3 week
Primary Clinical evaluation of using theobromine toothpaste(4%) for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
1 week
Primary Clinical evaluation of using theobromine toothpaste(4%) for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
2 week
Primary Clinical evaluation of using theobromine toothpaste(4%) for children Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent.
Gingival scores will be assessed with gingival index(loe and silness).
3 week
See also
  Status Clinical Trial Phase
Completed NCT04881357 - Antiplaque/Antigingivitis Effect of Lacer Oros Integral N/A
Completed NCT04561960 - Efficacy of Miswak in Oral Hygiene Maintenance Phase 4
Completed NCT04025684 - Efficacy of Manual Toothbrushes in Removing Dental Plaque N/A
Completed NCT03394729 - Effect of a Propolis Tablet on the Saliva and the Amount of Adolescent Dental Plaque Microbes Phase 2/Phase 3
Completed NCT04485520 - Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans N/A
Completed NCT02884817 - Essential Oil+ELA, Plaque and Gingivitis Phase 4
Completed NCT02552589 - Effect of Toothpaste on the Reduction of Plaque and Inflammation N/A
Completed NCT02194023 - Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%. Phase 2
Completed NCT01237782 - Efficacy of a Propolis-based Denture Cleanser N/A
Completed NCT00758394 - Clinical Study to Compare Dental Plaque Control Phase 3
Completed NCT00254345 - Effect of Provisional-Crown Surface Coating on Biofilm Formation Phase 1
Completed NCT05579938 - Effect of Enzymes on Dental Biofilm Accumulation N/A
Completed NCT05038293 - Efficacy of Plaque Removal of a Novel Brushing Device N/A
Terminated NCT05082103 - Effect of Enzymes on Dental Biofilm Accumulation in Healthy Individuals N/A
Not yet recruiting NCT06081868 - RCT on Effectiveness of Oral Health Preventive Programmes in School Children in Uganda N/A
Completed NCT05853679 - Regular Antibacterial Photodynamic Therapy on Oral Hygiene in Elderly Residents N/A
Completed NCT05521230 - Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software Phase 1
Completed NCT03311438 - Oral Health Intervention Program for Children With Congenital Heart Defects N/A
Enrolling by invitation NCT06122636 - Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC N/A
Not yet recruiting NCT05852145 - Oral Changes With Caloric and no Caloric Sweeteners Phase 1/Phase 2